Inflammatory responses in the atria: Should they stay or should they go?

Heart Rhythm

Volumn 8, Issue 2, 2011, Pages 286-287

  Duffy, Heather S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELL METABOLISM; GENETIC DISORDER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; INFLAMMATION; LIPID TRANSPORT; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 79251587484     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.11.006     Document Type: Editorial

References (21)

1. W.B. Kannel, and E.J. Benjamin Current perceptions of the epidemiology of atrial fibrillation Cardiol Clin 27 2009 13 24
2. C. Sanoski Clinical, economic, and quality of life impact of atrial fibrillation J Man Care Pharm Suppl 15 6b 2009 S4 S9
3. K. Lakshminarayan, C.A. Solid, A.J. Collins, D.C. Anderson, and C.A. Herzog Atrial fibrillation and stroke in the general medicare population Stroke 37 2006 1969 1974
4. de Toledo Ferraz Alves TC, Ferreira LK, Wajngarten M, Busatto GF. Cardiac disorders as risk factors for Alzheimer's disease. J Alzheimers Dis 20:749763.
5. O. Kume, N. Takahashi, and O. Wakisaka Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats Heart Rhythm 2011 278 285
6. P. Sertznig, M. Seifer, W. Tilgen, and J. Reichrath Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases Am J Clin Derm 9 1 2010 16 31
7. A. Koppen, and E. Kalkhoven Brown vs. white adipocytes: the PPAR gamma coregulator story FEBS Lett 584 2010 3250 3259
8. M. Shimano, Y. Tsuji, and Y. Inden Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure Heart Rhythm 5 2008 451 459
9. T. Yamashita, A. Sekiguchi, and Y. Iwasaki Recruitment of immune cells across atrial endocardium in human atrial fibrillation Circ J 74 2010 262 270
10. C.S. Lin, and C.H. Pan Regulatory mechanisms of atrial remodeling in atrial fibrillation Cell Mol Life Sci 65 2008 1489 1508
11. Burstein B, Qi XY, Yeh YH, Calderone A, Nattel S. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. 2007;76:442452.
12. H. Lal, S.K. Verma, and D.M. Foster Integrins and proximal signaling mechanisms in cardiovascular disease Front Biosci 14 2009 2307 2334
13. H.S. Duffy, and A.L. Wit Is there a role for remodeled connexins in AF? No simple answers JMCC 44 2008 4 13
14. R.J. Jha Thiazolidinediones-the new insulin enhancers Clin Exp Hypertens 21 1-2 1999 157 166
15. D. Krische The glitazones: proceed with caution West J Med 173 2000 54 57
16. P.S. Gillies, and C.J. Dunn Pioglitazone Drugs 60 2000 333 343
17. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 79 82
18. W.A. Hsueh, and R.E. Law PPARgamma and atherosclerosis: effects on cell growth and movement Arterioscler Thromb Vasc Biol 21 12 2001 1891 1895
19. E.C. Hirsche, T. Breidert, E. Rousselet, S. Hunot, A. Hartmann, and P.P. Michel The role of glial reaction and inflammation in Parkinson's disease Ann NY Acad Sci 991 2003 214 228
20. H.A. Pershadsingh Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis? Expert Opin Investig Drugs 13 2004 215 228
21. T. Lawrence, and C. Fong The resolution of inflammation: anti-inflammatory roles for NF-kappaB Int J Biochem Cell Biol 42 2010 519 523